1,403
Participants
Start Date
April 1, 2022
Primary Completion Date
December 9, 2024
Study Completion Date
December 9, 2024
Gardasil ® 9
"GARDASIL 9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of the following diseases: Cervical, vulvar, vaginal, and anal cancer, and Genital warts (condyloma acuminata) caused by Human Papillomavirus (HPV).~0.5-mL suspension for intramuscular injection as a single-dose vial and prefilled syringe at the following regimen/schedule: 9 through 14 years - 2-dose at 0, 6 to 12 months OR 3-dose at 0, 2, 6 months 15 through 45 years - 3-dose at 0, 2, 6 months"
AHF Lamvelase, Manzini
AHF Manzini, Manzini
Raleigh Fitkin Memorial Hospital, Manzini
AHF Matsapha, Matsapha
Baylor College of Medicine - Bristol Myers-Squibb Children's Clinical Centre of Excellence, Mbabane
Jhpiego
OTHER
Merck Sharp & Dohme LLC
INDUSTRY
Columbia University
OTHER